Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients

In the era of immunotherapies there is an urgent need to implement the use of circulating biomarkers in clinical practice to facilitate personalized therapy and to predict treatment response. We conducted a prospective study to evaluate the usefulness of circulating exosomal-PD-L1 in melanoma patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Extracell Vesicles
Autors principals: Cordonnier, Marine, Nardin, Charlée, Chanteloup, Gaëtan, Derangere, Valentin, Algros, Marie-Paule, Arnould, Laurent, Garrido, Carmen, Aubin, François, Gobbo, Jessica
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6968537/
https://ncbi.nlm.nih.gov/pubmed/32002173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20013078.2019.1710899
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars